ITHACA, N.Y.--(BUSINESS WIRE)--Rheonix Inc. announced today that the United States Food and Drug Administration (FDA) has issued an expanded Emergency Use Authorization (EUA) for the Rheonix COVID-19™ ...
Vivera Pharmaceuticals announced the launch of an exclusive partnership with OmeCare, a leading CLIA-certified global clinical laboratory provider. With results in less than 48 hours, the Vivera ...
For the detection of SARS-CoV-2, the infection that causes COVID 19, the multi-disciplinary team at the 88 MDG’s COVID Specimen Collection site will obtain a nasal specimen from the patient, according ...
WASHINGTON, D.C. – The Food and Drug Administration announced Saturday that it has authorized an at-home sample collection kit that can then be sent to specified laboratories for COVID-19 diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results